UK clinical trials - updated daily from ClinicalTrials.gov
Explore clinical trials and treatment pathways for conditions across the UK. Each condition page shows treatment options, current research, and links to active trials.
HER2+, HR+, Triple Negative
NSCLC, SCLC, all subtypes
Localised to mCRPC
Leukaemia, lymphoma, myeloma
Bowel cancer, colon, rectal
PDAC, FOLFIRINOX, targeted therapy
BRCA, PARP inhibitors, HRD
HPV-related, immunotherapy
Womb cancer, MSI-H, immunotherapy
BRAF, immunotherapy, targeted therapy
Oral, throat, HPV-positive
Glioblastoma, astrocytoma, IDH
RCC, immunotherapy combinations
NMIBC, MIBC, immunotherapy
HCC, locoregional, immunotherapy
Adenocarcinoma, squamous, chemoradiation
SCLC, immunotherapy, bispecifics
Gastric, HER2+, immunotherapy
RRMS, SPMS, PPMS, DMTs
Levodopa, DBS, neuroprotection
Anti-amyloid, lecanemab, MCI
Seizure disorder, VNS, surgery
CGRP inhibitors, Botox, chronic
We have detailed treatment pathways for 40+ conditions - see the full treatment roadmap with trial opportunities at every stage.
Explore All Pathways →